Traditional Chinese medicine composition for treating hyperlipidemia

Abstract

The invention discloses a traditional Chinese medicine composition for treating hyperlipidemia. The traditional Chinese medicine composition is prepared from, by weight, 10-30 parts of herbal taxilli, 10-20 parts of poria cocos, 5-15 parts of rhizoma curcumae longae, 10-20 parts of rhizoma alismatis, 10-20 parts of rhizoma corydalis, 10-20 parts of herbal andrographis, 5-15 parts of safflowers, 10-20 parts of trogopterus dung, 10-20 parts of radix asparagi, 5-15 parts of radix et rhizoma rhei, 10-20 parts of semen plantaginis, 10-20 parts of gentian, 5-15 parts of pericarpium citri reticulatae viride, 10-20 parts of concha margaritifera, 10-20 parts of lumbricus, 10-20 parts of fructus corni, 5-15 parts of concretion in bamboo stems, 10-20 parts of leaves of cluster mallow, 10-20 parts of fructus chaenomelis, 10-20 parts of semen cassiae torae, 5-15 parts of rhizoma curcumae, 10-20 parts of folium mori, 10-20 parts of rhizoma airtrodiae and 5-15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the effects of cleaning fat and dissolving turbidity, eliminating phlegm and regulating qi, benefiting the liver and kidney, and discharging fire and removing stagnation, and is remarkable in hyperlipidemia treatment effect and reliable in effect.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating hyperlipidemia. Background technique [0002] Hyperlipidemia refers to that the content of one or several lipid components in human plasma exceeds the normal maximum limit. This disease occupies a very important position in nutritional and metabolic diseases, and is one of the main factors leading to atherosclerosis. It is closely related to the occurrence of hypertension, coronary heart disease and cerebrovascular disease, and is regarded as the three major factors of coronary heart disease. one. In my country, this disease is not uncommon, and its morbidity and mortality have been increasing year by year in recent years, especially in middle-aged and elderly people. The primary etiology of this disease is unknown, and there are many family and genetic histories. At present, lipi...

AI Technical Summary

Problems solved by technology

At present, lipid-lowering drugs are mostly used in clinical treatment, but most of them have side effects and the curative effect is unstable